Search hospitals > Alaska > Anchorage
Anchorage Oncology Centre
Claim this profileAnchorage, Alaska 99508
Global Leader in Thyroid Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Stomach Cancer
Conducts research for Relapse
203 reported clinical trials
6 medical researchers
Summary
Anchorage Oncology Centre is a medical facility located in Anchorage, Alaska. This center is recognized for care of Thyroid Cancer, Breast Cancer, Lung Cancer, Stomach Cancer, Relapse and other specialties. Anchorage Oncology Centre is involved with conducting 203 clinical trials across 429 conditions. There are 6 research doctors associated with this hospital, such as Alison K. Conlin, Charles W. Drescher, Nitya Alluri, and Krishna C. Alluri.Area of expertise
1Thyroid Cancer
Global LeaderStage IV
Stage III
Stage I
2Breast Cancer
Global LeaderHER2 negative
Stage IV
ER positive
Top PIs
Alison K. ConlinProvidence Portland Medical Center6 years of reported clinical research
Expert in Thyroid Cancer
Expert in Breast Cancer
107 reported clinical trials
183 drugs studied
Charles W. DrescherProvidence Portland Medical Center8 years of reported clinical research
Expert in Thyroid Cancer
Studies Uterine Tumors
53 reported clinical trials
99 drugs studied
Nitya AlluriProvidence Portland Medical Center1 year of reported clinical research
Expert in Thyroid Cancer
Studies Relapse
28 reported clinical trials
79 drugs studied
Krishna C. AlluriProvidence Portland Medical Center5 years of reported clinical research
Expert in Thyroid Cancer
Studies Stomach Cancer
26 reported clinical trials
63 drugs studied
Clinical Trials running at Anchorage Oncology Centre
Breast Cancer
Bladder Cancer
Lung Cancer
Pancreatic Cancer
Thyroid Cancer
Non-Small Cell Lung Cancer
Multiple Myeloma
Bladder Carcinoma
Pancreatic Carcinoma
Stomach Cancer
Carvedilol
for Preventing Heart Problems in HER2 Positive Breast Cancer
This phase III trial studies how well carvedilol works in preventing cardiac toxicity in patients with human epidermal growth factor receptor (HER)-2-positive breast cancer that has spread to other places in the body. A beta-blocker, such as carvedilol, is used to treat heart failure and high blood pressure, and it may prevent the heart from side effects of chemotherapy.
Recruiting2 awards Phase 323 criteria
Shorter Chemo-Immunotherapy Without Anthracyclines
for Breast Cancer
This phase III trial compares the effects of shorter chemotherapy (chemo)-immunotherapy without anthracyclines to usual chemo-immunotherapy for the treatment of early-stage triple negative breast cancer. Paclitaxel is in a class of medications called anti-microtubule agents. It stops cancer cells from growing and dividing and may kill them. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of cancer cells. Cyclophosphamide is in a class of medications called alkylating agents. It works by damaging the cell's deoxyribonucleic acid (DNA) and may kill cancer cells. It may also lower the body's immune response. Docetaxel is in a class of medications called taxanes. It stops cancer cells from growing and dividing and may kill them. Doxorubicin is an anthracycline chemotherapy drug that damages DNA and may kill cancer cells. Pembrolizumab may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Shorter treatment without anthracycline chemotherapy may work the same as the usual anthracycline chemotherapy treatment for early-stage triple negative breast cancer.
Recruiting2 awards Phase 347 criteria
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Anchorage Oncology Centre?
Anchorage Oncology Centre is a medical facility located in Anchorage, Alaska. This center is recognized for care of Thyroid Cancer, Breast Cancer, Lung Cancer, Stomach Cancer, Relapse and other specialties. Anchorage Oncology Centre is involved with conducting 203 clinical trials across 429 conditions. There are 6 research doctors associated with this hospital, such as Alison K. Conlin, Charles W. Drescher, Nitya Alluri, and Krishna C. Alluri.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.